ArticleMediterranean journal of rheumatology2022
Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors.
Armen Yuri Gasparyan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it